ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,421.03
0.85%
Dow Jones
38,712.21
-0.09%
US Dollar vs MXN
18.76604
0.03%
Brent Oil
81.695
-0.74%
Bitcoin
67,239.88
-1.48%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Palisade Bio Inc (PALI)

  7. Palisade Bio Inc (PALI) Noticias

PALI Palisade Bio Inc

4.46
0.00 (0.00%)
Pre Mercado
Última actualización: 03:09:35
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Palisade Bio Inc PALI NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 4.46 03:09:35
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
4.46
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
12/6/202420:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/6/202420:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/6/202407:30GLOBEPalisade Bio Announces Notice of Allowance for Canadian..
10/6/202408:15GLOBEPalisade Bio to Present at the Virtual Investor Pitch..
30/5/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202418:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/5/202414:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202405:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202415:50EDGAR2Form ARS - Annual Report to Security Holders
22/5/202415:48EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/5/202415:45EDGAR2Form DEF 14A - Other definitive proxy statements
21/5/202407:30GLOBEPalisade Bio’s Lead Product Candidate, PALI-2108..
17/5/202415:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
14/5/202407:05GLOBEPalisade Bio Reports First Quarter 2024 Financial Results..
13/5/202415:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/5/202415:52EDGAR2Form 8-K - Current report
08/5/202417:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202417:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/5/202416:06EDGAR2Form S-3 - Registration statement under Securities Act of..
07/5/202407:30GLOBEPalisade Bio Appoints Margery Fischbein to its Board of..
07/5/202406:30GLOBEPalisade Bio Announces Closing of $4 Million Private..
02/5/202407:30GLOBEPalisade Bio Announces $4 Million Private Placement Priced..
01/5/202407:30GLOBEPalisade Bio’s Lead Product Candidate, PALI-2108..
23/4/202407:30GLOBEPalisade Bio Enters into Strategic Collaboration with Strand..
16/4/202407:30GLOBEPalisade Bio Successfully Demonstrates Bioactivation of..
11/4/202408:15GLOBEPalisade Bio to Participate in the Virtual Investor Lunch..
10/4/202407:15GLOBEPalisade Bio Presents Development Overview of PALI-2108 at..
03/4/202416:30GLOBEPalisade Bio Announces 1-for-15 Reverse Stock Split
27/3/202407:00GLOBEPalisade Bio Reports Year End 2023 Financial Results and..
06/3/202415:35EDGAR2Form 8-K - Current report
15/2/202407:35GLOBEPalisade Bio to Present at Digestive Disease Week (DDW) 2024
14/2/202413:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202419:10EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202415:38EDGAR2Form 8-K - Current report
13/2/202414:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202414:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202407:35GLOBEPalisade Bio Provides Corporate Update and Reiterates..
09/2/202415:03EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202415:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202415:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202413:40GLOBECorrection Notice of Palisade Bio’s Press Release Announcing..
08/2/202407:05GLOBEPalisade Bio Announces Formation of Clinical Advisory Board..
07/2/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202416:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
06/2/202416:00EDGAR2Form DEF 14A - Other definitive proxy statements
06/2/202409:29EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202407:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
PALI
Palisade Bio
TG
RBG
Rottneros AB
LSE
HITD
H S&p Ind Tech
CRTO
ACHUSD
Alchemy
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados